Apotheek Tobback SA
Apotheek Tobback reported total assets of 478,492 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Apotheek Tobback shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +56 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Tobback's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 44,010 € | ||||
| Equity | 352,027 € | ||||
| Cash | 244,487 € | ||||
| EBITDA | 108,557 € | ||||
| Total assets | 478,492 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Apotheek Tobback's financial analysis
- Solvency73.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Tobback
Apotheek Tobback's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0466.562.872
- VAT number
- BE0466562872
- Peppol
- Registered · 0208:0466562872 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 06 Aug 1999
- Registered office
- 2840 Rumst
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Tobback (SA) has been based in Rumst since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 44,010 € and equity of 352,027 €; its revenue is not published. Its solvency stands at 73.6%, above the median of its sector (44.2%).
Companies similar to Apotheek Tobback
Companies in the same business, of comparable size and area, outside its group.
- MV Pharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 469,186 €
- City-Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 478,952 €
- delta SUD PHARMA Retail sale of pharmaceutical products Virton · balance sheet 477,640 €
- De Maeyer Groot-Bijgaarden Retail sale of pharmaceutical products Dilbeek · balance sheet 479,884 €
- Pharmalixhe Retail sale of pharmaceutical products Visé · balance sheet 476,967 €
- Vereenooghe LDL Retail sale of pharmaceutical products Lendelede · balance sheet 377,699 €
- Anafarma Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 474,117 €
- Internationale Apotheek Retail sale of pharmaceutical products Antwerp · balance sheet 483,003 €
Frequently asked questions about Apotheek Tobback
What is the revenue of Apotheek Tobback?
Apotheek Tobback files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Tobback?
In Belgium, the VAT number is the company number prefixed with BE: BE0466562872 for Apotheek Tobback, if the company is VAT-registered. Its company number (CBE) is 0466.562.872.
Where is the registered office of Apotheek Tobback?
According to the CBE register, the registered office of Apotheek Tobback is in 2840 Rumst.
What is the equity of Apotheek Tobback?
At the close of the 2025 financial year, the equity of Apotheek Tobback amounts to 352,027 €, a solvency of 73.6% of total assets.
Who manages Apotheek Tobback?
The register lists 3 active mandates at Apotheek Tobback. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Tobback
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →